• [email protected]
  • +971 507 888 742
Submit Manuscript
SciAlert
  • Home
  • Journals
  • Information
    • For Authors
    • For Referees
    • For Librarian
    • For Societies
  • Contact
  1. Journal of Medical Sciences
  2. Vol 8 (4), 2008
  3. 400-404
  • Online First
  • Current Issue
  • Previous Issues
  • More Information
    Aims and Scope Editorial Board Guide to Authors Article Processing Charges
    Submit a Manuscript

Journal of Medical Sciences

Year: 2008 | Volume: 8 | Issue: 4 | Page No.: 400-404
DOI: 10.3923/jms.2008.400.404

Facebook Twitter Digg Reddit Linkedin StumbleUpon E-mail

Article Trend



Total views 197

Authors


B. Ahmed

Country: Egypt

Md. Ashraf Abd Elmawgoud

Country: Egypt

R. Doaa

Country: Egypt

Keywords


  • Intraperitoneal
  • bupivacaine
  • meperidine
  • dexmedetomidine
  • laparoscopic gynecologic surgery
Research Article

Antinociceptive Effect of (α2-Adrenoceptor Agonist) Dexmedetomidine vs Meperidine, Topically, after Laparoscopic Gynecologic Surgery

B. Ahmed, Md. Ashraf Abd Elmawgoud and R. Doaa
This prospective double blinded study compared the analgesic effect of intraperitoneal dexmedetomidine or meperidine with bupivacaine to intraperitoneal bupivacaine alone in laparoscopic gynecologic surgery. Sixty female patients undergone elective laparoscopic gynecologic surgery given a standardized general anesthesia were randomly allocated into one of three equal sized groups; Group B: intraperitoneal 50 mL bupivacaine 0.25%, Group B+M: intraperitoneal 50 mL bupivacaine 0.25%+1 mg kg-1 meperidine and Group B+D: intraperitoneal 50 mL bupivacaine 0.25%+1 μg kg-1 dexmedetomidine. The following parameters were evaluated: (1) Time to first request of analgesia, (2) The incidence and severity of postoperative shoulder pain for 24 h postoperatively, (3): The amount of postoperative PCA morphine for 24 h postoperatively. Times to first request of analgesia was significantly short in group B compared to the other 2 groups (p<0.05). Doses of intravenous PCA morphine consumed at 0-6, 6-12, 12-18, 18-24 and 0-24 h were significantly less in groups B+M and B+D compared to group B (p<0.05) with no significant difference between groups B+M and B+D. The incidence and severity of shoulder pain were less in group B+M and B+D compared to group B (p<0.05) with no significant difference between the later two groups. Intraperitoneal instillation of meperidine (1 mg kg-1) or dexmedetomidine (1 μg kg-1) in combination with bupivacaine 0.25% in female patients undergoing laparoscopic gynecologic surgery significantly decreases the postoperative analgesic requirements and decreased the incidence of shoulder pain compared to intraperitoneal bupivacaine 0.25% alone.
PDF Fulltext XML References Citation

How to cite this article

B. Ahmed, Md. Ashraf Abd Elmawgoud and R. Doaa, 2008. Antinociceptive Effect of (α2-Adrenoceptor Agonist) Dexmedetomidine vs Meperidine, Topically, after Laparoscopic Gynecologic Surgery. Journal of Medical Sciences, 8: 400-404.

DOI: 10.3923/jms.2008.400.404

URL: https://scialert.net/abstract/?doi=jms.2008.400.404

Related Articles

Effect of Increased Dose of Dexmedetomidine Vis-à-vis Addition of Fentanyl on Clinical and Cardio-respiratory Actions of Dexmedetomidine-midazolam-ketamine Anaesthesia in Dogs
Effects of Midazolam or Midazolam-Fentanyl on Sedation and Analgesia Produced by Intramuscular Dexmedetomidine in Dogs

Leave a Comment


Your email address will not be published. Required fields are marked *

Useful Links

  • Journals
  • For Authors
  • For Referees
  • For Librarian
  • For Socities

Contact Us

Office Number 1128,
Tamani Arts Building,
Business Bay,
Deira, Dubai, UAE

Phone: +971 507 888 742
Email: [email protected]

About Science Alert

Science Alert is a technology platform and service provider for scholarly publishers, helping them to publish and distribute their content online. We provide a range of services, including hosting, design, and digital marketing, as well as analytics and other tools to help publishers understand their audience and optimize their content. Science Alert works with a wide variety of publishers, including academic societies, universities, and commercial publishers.

Follow Us
© Copyright Science Alert. All Rights Reserved